People · Operator
Named in public records as an officer, director or promoter · active 2020–2020 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Solace Therapeutics Inc | — | Pharma | Series A | $28.4M | $202.2M | 2020 |
David R. Neustaedter at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David R. Neustaedter on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian R. Smith | 1 | 21 |
| J. Daniel Cole | 1 | 7 |
| Kevin G Connors | 1 | 3 |
| Kevin H. Connors | 1 | 2 |
| William H. Gruber | 1 | 2 |
| John R. McDonough | 1 | 2 |
| Gerrit R. Adams | 1 | 1 |
| Dr. William Daniel Pintauro | 1 | 1 |
| John G. McDonough | 1 | 1 |
| Stacy G. Enxing Seng | 1 | 1 |
| Ali G. Behbahani | 1 | 1 |
| Ryan G. Drant | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.